News Categories
About Sanaria
Sanaria is a Maryland-based biotechnology company developing innovative vaccines that protect against malaria. We are focused on African children, the population most urgently in need of protection.
Latest News
The Annual International PfSPZ Consortium Met in Toronto, Canada on November 8th & 9th, 2025
The 2025 iPfSPZ-C meeting brought together scienti...
Sanaria’s CEO, Dr. Stephen L. Hoffman awarded the Walter Reed Medal at the American Society of Tropical Medicine’s Annual Conference
The Walter Reed Medal is awarded every year to rec...
International PfSPZ Consortium Met in New Orleans on November 11th & 12th, 2024
On November 11th and 12th, 2024, the International...
Employee of the Month: Tint Wai
The Sanaria employee of the month for August 2024 ...
Sanaria’s Recent Lancet ID Publication Featured in devex Article
Sanaria's recent publication in the Lancet Infecti...
